Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Outlook Therapeutics Inc. (OTLK)

0.8999   -0.053 (-5.61%) 02-24 16:00
Open: 0.88 Pre. Close: 0.9534
High: 0.92 Low: 0.87
Volume: 1,231,499 Market Cap: 39M
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, a proprietary ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and license agreements with MTTR, LLC; IPCA Laboratories Limited; Laboratorios Liomont, S.A. de C.V.; BioLexis Pte. Ltd.; and Zhejiang Huahai Pharmaceutical Co., Ltd. The company was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was founded in 2010 and is headquartered in Cranbury, New Jersey.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.921 - 0.928 0.928 - 0.933
Low: 0.854 - 0.862 0.862 - 0.869
Close: 0.888 - 0.9 0.9 - 0.909

Technical analysis

as of: 2020-02-24 4:46:08 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 1.19     One year: 1.31
Support: Support1: 0.85    Support2: 0.71
Resistance: Resistance1: 1.02    Resistance2: 1.12
Pivot: 0.97
Moving Average: MA(5): 0.96     MA(20): 0.96
MA(100): 1.09     MA(250): 2.23
MACD: MACD(12,26):     Signal(9): 0.01
Stochastic oscillator: %K(14,3): 27.20     %D(3): 39.18
RSI: RSI(14): 43.35
52-week: High: 9.20  Low: 0.52  Change(%): -89.3
Average Vol(K): 3-Month: 110244  10-Days: 43604

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
OTLK has closed above bottom band by 0.4%. Bollinger Bands are 67.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to OTLK's normal range. The bands have been in this narrow range for 21 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 17 May 2019 13:24:45 +0000
Health Care Sector Update for 05/17/2019: ACHN, OTLK, MOR, JNJ, PFE, ABT, MRK, AMGN

Fri, 17 May 2019 18:07:02 +0000
Health Care Sector Update for 05/17/2019: HROW,AGN,OTLK,MOR

Fri, 17 May 2019 20:05:39 +0000
Health Care Sector Update for 05/17/2019: VRML,HROW,AGN,OTLK,MOR

Wed, 10 Apr 2019 17:47:41 +0000
Health Care Sector Update for 04/10/2019: IMMU,GH,OTLK

Wed, 10 Apr 2019 19:54:32 +0000
Health Care Sector Update for 04/10/2019: PTE,IMMU,GH,OTLK

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqCM
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 43.09
Shares Float (M) 14.98
% Held by Insiders 59.67
% Held by Institutions 5.38
Shares Short (K) 2000
Shares Short P. Month (K)

Stock Financials

EPS -1.981
Book Value (p.s.) -0.560
PEG Ratio
Profit Margin
Operating Margin -307.25
Return on Assets (ttm) -79.4
Return on Equity (ttm)
Qtrly Rev. Growth 658.3
Gross Profit (p.s.) -0.363
Sales Per Share
EBITDA (p.s.) -0.503
Qtrly Earnings Growth
Operating Cash Flow (M) -32.29
Levered Free Cash Flow (M) -22.38

Stock Valuations

P/E -0.45
P/E Growth Ratio -0.06
P/BV -1.61
P/S 1.99
P/CF -1.20

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2019-03-17
Last Split Ratio 0.13
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.